Antimicrobial Agents — MCQs

Antimicrobial Agents Indian Medical PG Practice Questions and MCQs

Question 281: Which of the following penicillins is not administered orally?

A. Amoxicillin
B. Carbenicillin (Correct Answer)
C. Cloxacillin
D. Phenoxymethyl penicillin

Explanation: **Explanation:** The correct answer is **Carbenicillin**. **1. Why Carbenicillin is the correct answer:** Carbenicillin belongs to the **carboxypenicillin** group (extended-spectrum penicillins). It is **acid-labile**, meaning it is rapidly degraded by gastric acid in the stomach. Consequently, it has very poor oral bioavailability and must be administered parenterally (IV/IM) to achieve therapeutic systemic concentrations. Note: An ester prodrug, *Carbenicillin indanyl*, exists for oral use, but it is only used for UTIs as it does not achieve systemic levels. **2. Why the other options are incorrect:** * **Amoxicillin:** An aminopenicillin that is **acid-stable** and has excellent oral absorption (better than Ampicillin). It is the most common oral penicillin used in clinical practice. * **Cloxacillin:** An antistaphylococcal (penicillinase-resistant) penicillin. It is **acid-stable** and specifically designed for oral administration to treat mild-to-moderate integumentary staphylococcal infections. * **Phenoxymethyl penicillin (Penicillin V):** Unlike Penicillin G (which is acid-labile), Penicillin V is **acid-stable** and is the standard oral form of natural penicillin. **3. Clinical Pearls for NEET-PG:** * **Acid-Labile Penicillins (Parenteral only):** Penicillin G, Carbenicillin, Ticarcillin, Piperacillin. * **Acid-Stable Penicillins (Oral):** Penicillin V, Amoxicillin, Ampicillin, Cloxacillin, Dicloxacillin. * **High-Yield Fact:** Carbenicillin is rarely used today; it has been largely replaced by **Piperacillin** due to the latter's higher potency against *Pseudomonas aeruginosa* and lower sodium load (Carbenicillin carries a risk of fluid overload and hypokalemia).

Question 282: Which of the following drugs has cochlear involvement more than vestibular involvement?

A. Sisomycin
B. Kanamycin (Correct Answer)
C. Gentamycin
D. Streptomycin

Explanation: Aminoglycosides are notorious for their **ototoxicity**, which occurs due to the accumulation of the drug in the perilymph and endolymph, leading to the destruction of sensory hair cells. Degeneration of hair cells and neurons in the cochlea correlates with the loss of hearing [1]. This toxicity is broadly categorized into **vestibular** (balance) and **cochlear** (hearing) involvement. **1. Why Kanamycin is Correct:** Aminoglycosides exhibit a preference for specific parts of the inner ear. **Kanamycin**, along with Amikacin and Neomycin, is primarily **cochleotoxic**. It causes the destruction of the outer hair cells in the Organ of Corti, leading to permanent high-frequency hearing loss. **2. Analysis of Incorrect Options:** * **Streptomycin:** Primarily **vestibulotoxic**. Its unwanted effects are ototoxicity (mainly vestibular) [3]. It targets the sensory cells of the cristae ampullaris, leading to vertigo, ataxia, and loss of balance. * **Gentamycin:** Primarily **vestibulotoxic**. Ototoxicity from gentamicin manifests itself mainly as vestibular dysfunction [2]. Like streptomycin, it affects balance more frequently than hearing. * **Sisomycin:** Primarily **vestibulotoxic**. It is a derivative of Gentamycin and shares a similar toxicity profile. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Mnemonic for Cochleotoxicity:** "**A**ll **N**ew **K**ids" (**A**mikacin, **N**eomycin, **K**anamycin). * **Mnemonic for Vestibulotoxicity:** "**S**ome **G**uys" (**S**treptomycin, **G**entamycin). * **Tobramycin** is unique as it affects both vestibular and cochlear functions almost equally. * **Risk Factors:** Ototoxicity is potentiated by the concurrent use of **Loop Diuretics** (e.g., Furosemide, Ethacrynic acid). * **Monitoring:** Since aminoglycosides are excreted renally, toxicity is higher in patients with renal impairment. Monitoring peak and trough levels is essential.

Question 283: Which antibiotic is recommended for the treatment of Toxic Shock Syndrome?

A. Linezolid
B. Clindamycin (Correct Answer)
C. Cephalexin
D. Quinupristin and dalfopristin

Explanation: **Explanation:** The correct answer is **Clindamycin**. **Why Clindamycin is the drug of choice:** Toxic Shock Syndrome (TSS), caused by *Staphylococcus aureus* or *Streptococcus pyogenes*, is primarily a **toxin-mediated disease** (TSST-1 and Streptococcal pyrogenic exotoxins). While beta-lactams (like Penicillin or Nafcillin) kill the bacteria by inhibiting cell wall synthesis, they do not stop the production of pre-formed toxins. Clindamycin is a **protein synthesis inhibitor** (binding to the 50S ribosomal subunit). Its therapeutic advantage in TSS is twofold: 1. **Suppression of Toxin Production:** It shuts down the bacterial ribosomes, immediately halting the synthesis of the superantigen toxins responsible for the cytokine storm. 2. **Eagle Effect:** Unlike beta-lactams, clindamycin’s efficacy is not affected by the "inoculum effect" (where bacteria in the stationary phase are less susceptible to cell-wall acting agents). **Analysis of Incorrect Options:** * **Linezolid:** While it also inhibits protein synthesis and can be used in MRSA-related TSS, Clindamycin remains the classic, first-line recommendation in standard protocols due to extensive clinical evidence. * **Cephalexin:** This is a first-generation cephalosporin used for minor skin infections. It lacks the potent toxin-suppressing properties required for systemic TSS. * **Quinupristin/Dalfopristin:** These are reserved for Vancomycin-resistant *Enterococcus faecium* (VRE) and are not standard therapy for TSS. **NEET-PG High-Yield Pearls:** * **Mechanism:** Clindamycin inhibits the 50S subunit (translocation step). * **Side Effect:** Most common cause of *Clostridioides difficile* associated diarrhea (Pseudomembranous colitis). * **Clinical Use:** Also used for anaerobic infections above the diaphragm and as prophylaxis for bacterial endocarditis in penicillin-allergic patients. * **Combination Therapy:** In clinical practice, Clindamycin is often paired with a bactericidal agent (like Vancomycin or Piperacillin-Tazobactam) for synergistic effect.

Question 284: Elvucitabine acts as which of the following classes of antiviral agents?

A. Reverse transcriptase inhibitor (Correct Answer)
B. Protease inhibitor
C. Entry inhibitor
D. Integrase inhibitor

Explanation: **Explanation:** **Elvucitabine** is an L-cytosine nucleoside analog. It functions as a **Nucleoside Reverse Transcriptase Inhibitor (NRTI)**. Its mechanism of action involves being phosphorylated into its active triphosphate form, which then competes with natural substrates for incorporation into the viral DNA chain. Once incorporated, it causes **premature chain termination** because it lacks the 3'-hydroxyl group necessary for forming phosphodiester bonds. It is particularly notable for its long half-life and potency against both HIV-1 and Hepatitis B Virus (HBV). **Analysis of Incorrect Options:** * **B. Protease Inhibitors (PIs):** These agents (e.g., Ritonavir, Atazanavir) inhibit the viral protease enzyme responsible for cleaving precursor polyproteins into functional proteins, preventing viral maturation. * **C. Entry Inhibitors:** These prevent the virus from entering the host cell. Examples include Maraviroc (CCR5 antagonist) and Enfuvirtide (fusion inhibitor). * **D. Integrase Inhibitors (INSTIs):** These agents (e.g., Dolutegravir, Raltegravir) block the integrase enzyme, preventing the integration of viral DNA into the host cell genome. **High-Yield Clinical Pearls for NEET-PG:** * **Dual Activity:** Like Lamivudine and Tenofovir, Elvucitabine has activity against both **HIV and HBV**. * **Resistance Profile:** It remains effective against certain HIV strains that have developed resistance to Lamivudine (specifically the **M184V mutation**). * **Pharmacokinetics:** It is characterized by a very long intracellular half-life (up to 100+ hours), allowing for potential once-weekly dosing.

Question 285: Which of the following drugs is used to prevent HIV transmission from an HIV-positive pregnant mother to her child?

A. Lamivudine
B. Stavudine
C. Nevirapine (Correct Answer)
D. Didanosine

Explanation: **Explanation:** The prevention of mother-to-child transmission (PMTCT) of HIV is a critical clinical priority. **Nevirapine**, a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), is the drug of choice in this context due to its unique pharmacokinetic profile. **Why Nevirapine is correct:** Nevirapine has excellent bioavailability and a long half-life. Most importantly, it rapidly crosses the placenta and is secreted in breast milk. In the classic "WHO Option A" protocol (and historical single-dose regimens), a single dose given to the mother at the onset of labor and a single dose to the newborn within 72 hours significantly reduces the risk of vertical transmission. While modern guidelines (Option B+) now favor lifelong Triple Antiretroviral Therapy (ART) for the mother (usually containing Tenofovir, Lamivudine, and Dolutegravir), Nevirapine remains the classic exam answer for PMTCT prophylaxis. **Why other options are incorrect:** * **Lamivudine (3TC), Stavudine (d4T), and Didanosine (ddI):** These are Nucleoside Reverse Transcriptase Inhibitors (NRTIs). While they are used as part of combination ART regimens during pregnancy to reduce viral load, they are not used as monotherapy for the specific prevention of transmission during labor. Stavudine and Didanosine are now rarely used due to high mitochondrial toxicity (lactic acidosis and peripheral neuropathy). **High-Yield Clinical Pearls for NEET-PG:** * **Zidovudine (AZT):** Historically the first drug used for PMTCT (PCTG 076 protocol). It is still used as infant prophylaxis for 6 weeks post-delivery. * **Drug of Choice (Current):** For a pregnant woman, the preferred regimen is **TDF + 3TC + DTG** (Tenofovir + Lamivudine + Dolutegravir). * **Nevirapine Side Effect:** Watch for Stevens-Johnson Syndrome (SJS) and hepatotoxicity. * **Post-Exposure Prophylaxis (PEP):** Should be started within 2 hours (ideally) and no later than 72 hours, continuing for 28 days.

Question 286: What is the drug of choice for Neisseria gonorrhoeae infection?

A. Ceftriaxone (Correct Answer)
B. Ciprofloxacin
C. Kanamycin
D. Cefaclor

Explanation: **Explanation:** **1. Why Ceftriaxone is the Correct Answer:** Ceftriaxone (a third-generation cephalosporin) is currently the **drug of choice (DOC)** for uncomplicated gonococcal infections of the cervix, urethra, and rectum. It is preferred due to its high efficacy, long half-life, and the rising resistance of *Neisseria gonorrhoeae* to other antibiotic classes. * **Mechanism:** It inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). * **Current Guidelines:** The CDC and WHO recommend a single intramuscular (IM) dose of Ceftriaxone. Note that since coinfection with *Chlamydia trachomatis* is common, Doxycycline is often added to the regimen unless Chlamydia has been excluded. **2. Why Other Options are Incorrect:** * **B. Ciprofloxacin:** While fluoroquinolones were once the mainstay of treatment, they are no longer recommended due to widespread global resistance (QRNG - Quinolone-resistant *N. gonorrhoeae*). * **C. Kanamycin:** This aminoglycoside is an alternative in specific geographical regions with high resistance profiles, but it is not the first-line agent globally due to toxicity and lower comparative efficacy. * **D. Cefaclor:** This is a second-generation cephalosporin. It is less potent against Gram-negative cocci like *Neisseria* compared to third-generation agents and is not used for definitive treatment. **3. High-Yield Clinical Pearls for NEET-PG:** * **Dose:** The standard dose for uncomplicated gonorrhea is **500 mg IM** (increased from 250 mg in recent guidelines to combat emerging resistance). * **Disseminated Gonococcal Infection (DGI):** Ceftriaxone remains the DOC but requires a longer duration of treatment (usually IV). * **Ophthalmia Neonatorum:** Ceftriaxone is the DOC for systemic treatment, while 0.5% Erythromycin ointment is used for prophylaxis. * **Alternative if Ceftriaxone is contraindicated:** A single dose of **Spectinomycin** (2g IM) or high-dose Azithromycin (though resistance is increasing).

Question 287: What is the mechanism of action of gentamicin?

A. Interference with DNA synthesis
B. Inhibition of transcription
C. Inhibition of translation (Correct Answer)
D. Inhibition of cell wall synthesis

Explanation: **Explanation:** **Mechanism of Action (Correct Answer: C)** Gentamicin is an **Aminoglycoside** antibiotic. Its primary mechanism of action is the **inhibition of protein synthesis (translation)** [1]. It acts by irreversibly binding to the **30S ribosomal subunit** [2]. This binding results in three specific effects [2]: 1. Interference with the initiation complex of translation. 2. Induction of **mRNA misreading**, leading to the synthesis of non-functional or toxic proteins [1]. 3. Breakup of polysomes into non-functional monosomes [1]. **Analysis of Incorrect Options:** * **A & B (DNA Synthesis/Transcription):** These processes are targeted by Quinolones (DNA gyrase/Topoisomerase IV) and Rifampin (RNA polymerase), respectively. Aminoglycosides do not directly interfere with nucleic acid synthesis. * **D (Cell Wall Synthesis):** This is the mechanism of Beta-lactams (Penicillins, Cephalosporins) and Glycopeptides (Vancomycin). While Aminoglycosides often work synergistically with cell wall inhibitors (which facilitate their entry into the cell), they do not inhibit the wall synthesis themselves [2]. **NEET-PG High-Yield Clinical Pearls:** * **Transport:** Aminoglycoside entry into bacteria is an **oxygen-dependent** process; therefore, they are ineffective against **anaerobes** [2]. * **Post-Antibiotic Effect (PAE):** They exhibit a significant PAE, allowing for once-daily dosing despite a short plasma half-life. * **Adverse Effects:** Characterized by the "3 N's": **N**ephrotoxicity (Acute Tubular Necrosis), **N**eurotoxicity (Neuromuscular blockade), and **N**on-reversible Ototoxicity (Vestibulocochlear damage) [3]. * **Teratogenicity:** Can cause fetal ototoxicity (Category D).

Question 288: Antimicrobials effective against anaerobic bacteria include the following EXCEPT:

A. Tobramycin (Correct Answer)
B. Clindamycin
C. Chloramphenicol
D. Metronidazole

Explanation: **Explanation:** The correct answer is **Tobramycin**. **1. Why Tobramycin is the correct answer:** Tobramycin is an **Aminoglycoside**. The fundamental mechanism of action for aminoglycosides involves an **oxygen-dependent transport system** to cross the bacterial cytoplasmic membrane. In anaerobic environments, this transport mechanism fails because there is no oxygen to fuel the electron transport chain required for drug uptake. Therefore, aminoglycosides are inherently ineffective against all obligate anaerobes (e.g., *Bacteroides*, *Clostridium*). **2. Why the other options are incorrect:** * **Metronidazole:** This is the "gold standard" for anaerobic infections. It is a prodrug that requires reductive activation by the enzyme **pyruvate:ferredoxin oxidoreductase**, which is only found in anaerobic organisms. * **Clindamycin:** A lincosamide that is highly effective against Gram-positive anaerobes and is a classic choice for infections "above the diaphragm" (e.g., aspiration pneumonia). * **Chloramphenicol:** A broad-spectrum bacteriostatic agent that has excellent activity against most anaerobes, including *Bacteroides fragilis*, though its use is limited by toxicity (e.g., Bone marrow suppression). **NEET-PG High-Yield Pearls:** * **Mnemonic for Aminoglycosides:** "A-mean-O-glycosides" (They need **O**xygen to work). * **Synergy:** Aminoglycosides are often combined with Cell Wall Synthesis Inhibitors (like Penicillins) because the latter break the cell wall, allowing the aminoglycoside to enter even if the transport system is sluggish. * **Clinical Rule of Thumb:** For anaerobic coverage, think **Metronidazole** (below the diaphragm/gut) and **Clindamycin** (above the diaphragm/lung).

Question 289: What is a drawback of artesunate?

A. Poor bioavailability
B. Rapid recrudescence of malaria (Correct Answer)
C. Hypoglycemia
D. Hemolysis

Explanation: **Explanation:** **Artesunate** is a water-soluble hemisuccinate derivative of artemisinin and is currently the drug of choice for severe malaria. **Why Rapid Recrudescence is the Correct Answer:** Artemisinins, including artesunate, are characterized by an extremely rapid onset of action and a very **short elimination half-life** (approximately 30–60 minutes). While they kill parasites faster than any other antimalarial, they do not remain in the blood long enough to eliminate the entire parasite biomass. If used as monotherapy for a short duration, surviving parasites can multiply once the drug concentration falls, leading to a high rate of **recrudescence** (return of symptoms). To prevent this, artesunate must always be followed by a long-acting partner drug as part of **Artemisinin-based Combination Therapy (ACT)**. **Analysis of Incorrect Options:** * **A. Poor bioavailability:** Artesunate actually has excellent bioavailability and can be administered IV, IM, orally, or rectally. * **C. Hypoglycemia:** This is a classic side effect of **Quinine**, caused by hyperinsulinemia. Artesunate is preferred over quinine because it does not cause hypoglycemia. * **D. Hemolysis:** While "Delayed Post-Artesunate Hemolysis" (PAH) can occur in rare cases, it is not the primary pharmacological drawback compared to the clinical challenge of recrudescence. Hemolysis is more classically associated with **Primaquine** in G6PD-deficient patients. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Production of free radicals via the cleavage of the endoperoxide bridge by parasite heme. * **Drug of Choice:** IV Artesunate is the gold standard for **Severe/Cerebral Malaria** (WHO guidelines). * **Safe in Pregnancy:** Artesunate is now considered safe for use in all trimesters of pregnancy for severe malaria.

Question 290: Quinolone antibiotics inhibit bacterial growth by affecting which of the following?

A. Reverse transcriptase
B. RNA polymerase
C. DNA polymerase
D. DNA gyrase (Correct Answer)

Explanation: **Explanation:** **Mechanism of Action (Why D is correct):** Quinolones and Fluoroquinolones (e.g., Ciprofloxacin, Levofloxacin) are bactericidal antibiotics that inhibit bacterial DNA synthesis. They target two key enzymes: 1. **DNA Gyrase (Topoisomerase II):** In Gram-negative bacteria, quinolones inhibit DNA gyrase, which is responsible for introducing negative supercoils into DNA to relieve the torsional stress (supercoiling) that occurs ahead of the replicating fork. 2. **Topoisomerase IV:** In Gram-positive bacteria, they primarily inhibit this enzyme, which is responsible for separating the interlinked daughter DNA strands (decatenation) after replication. **Analysis of Incorrect Options:** * **A. Reverse transcriptase:** This enzyme converts RNA into DNA. It is a target for Antiretroviral drugs (e.g., Zidovudine) used in HIV treatment, not antibacterial agents. * **B. RNA polymerase:** This enzyme is involved in transcription (DNA to RNA). It is the primary target of **Rifampicin**, used in the treatment of Tuberculosis. * **C. DNA polymerase:** This enzyme is responsible for synthesizing the new DNA strand by adding nucleotides. While essential for replication, it is not the target of quinolones. Antiviral drugs like Acyclovir target viral DNA polymerase. **High-Yield Clinical Pearls for NEET-PG:** * **Resistance:** Occurs via mutations in the *gyrA* or *parC* genes or through **Qnr proteins** (plasmid-mediated). * **Pharmacokinetics:** They exhibit **concentration-dependent killing** and have a significant Post-Antibiotic Effect (PAE). * **Adverse Effects:** Most characteristic are **tendon rupture/tendonitis** (especially in the elderly or those on steroids) and **QT interval prolongation**. * **Contraindications:** Generally avoided in pregnancy and children due to the risk of **cartilage toxicity** (arthropathy).

Practice by Chapter

Beta-Lactam Antibiotics

Practice Questions

Aminoglycosides

Practice Questions

Macrolides and Ketolides

Practice Questions

Tetracyclines

Practice Questions

Quinolones

Practice Questions

Sulfonamides and Trimethoprim

Practice Questions

Antimycobacterial Drugs

Practice Questions

Antifungal Agents

Practice Questions

Antiviral Drugs

Practice Questions

Antiparasitic Agents

Practice Questions

Principles of Antimicrobial Selection

Practice Questions

Antimicrobial Resistance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free